A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation

BACKGROUND: Bone and mineral disorders commonly affect kidney transplant (KTx) recipients and have been associated with a high risk of fracture. Bisphosphonates may prevent or treat bone loss in such patients, but there is concern that these drugs might induce adynamic bone disease (ABD). METHODS: I...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Soc Nephrol
Hlavní autoři: Marques, Igor Denizarde Bacelar, Araújo, Maria Júlia Correia Lima Nepomuceno, Graciolli, Fabiana Giorgetti, dos Reis, Luciene Machado, Pereira, Rosa Maria R., Alvarenga, Jackeline C., Custódio, Melani Ribeiro, Jorgetti, Vanda, Elias, Rosilene Motta, Moysés, Rosa Maria Affonso, David-Neto, Elias
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Nephrology 2019
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6362629/
https://ncbi.nlm.nih.gov/pubmed/30606784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018060656
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky